Reduction of myocardial leukocyte accumulation and myocardial infarct size following administration of BAY u3405, a thromboxane A2 receptor antagonist, in myocardial ischaemia-reperfusion injury
- 1 July 1993
- journal article
- inflammation
- Published by Springer Nature in Inflammation Research
- Vol. 39 (3-4) , 143-149
- https://doi.org/10.1007/bf01998967
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemie myocardiumPublished by Elsevier ,2002
- Endothelial, platelet and leukocyte interactions in ischemic heart disease: Insights into potential mechanisms and their clinical relevanceJournal of the American College of Cardiology, 1990
- Method for quantification of myocardial infarction and inflammatory cell infiltration in rat cardiac tissueJournal of Pharmacological Methods, 1988
- Neutrophils as potential participants in acute myocardial ischemia: Relevance to reperfusionJournal of the American College of Cardiology, 1988
- Platelets, endothelium, and vasospasm.Circulation, 1985
- Oxygen-Derived Free Radicals in Postischemic Tissue InjuryNew England Journal of Medicine, 1985
- Protection of Ischemic Cat Myocardium By CGS-13080, a Selective Potent Thromboxane A2 Synthesis InhibitorJournal of Cardiovascular Pharmacology, 1983
- The effect of ibuprofen on accumulation of indium-111-labeled platelets and leukocytes in experimental myocardial infarction.Circulation, 1982
- Influence of thromboxane inhibition on the severity of myocardial ischemia in catsCanadian Journal of Physiology and Pharmacology, 1980
- Experimental ischemic heart disease induced by thromboxane A2 in rabbits.Japanese Circulation Journal, 1978